Theratechnologies
- Country
- Ownership
- -
- Employees
- 58
- Market Cap
- -
- Introduction
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
Clinical Trials
9
Active:9
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
2
FDA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)No trials found
News
No news found